A team of researchers at NYU Langone Health and the Perlmutter Cancer Center has identified a potential therapeutic strategy for melanoma patients whose tumors harbor mutations in the neurofibromin 1 (NF1) gene and who do not respond to current immunotherapy treatments.
Melanoma News
Could AI help doctors better detect melanoma?
New research shows how artificial intelligence could result in more rapid and accurate diagnoses of melanoma and other skin conditions.
Optimizing Treatment for Symptomatic Melanoma Brain Metastases
Treatment for symptomatic melanoma brain metastases remains challenging, with limited efficacy from current standard immunotherapies like anti–PD-1 and anti-CTLA4.
Common Virus Improves Melanoma Treatment Response, Reduces Side Effects
A common virus carried by approximately half of adults worldwide may improve outcomes for melanoma patients receiving immunotherapy while also protecting against severe treatment-related side effects and limiting the spread, according to new research from the University of Oxford.